Koyama Tatsuki, Sampson Allan R, Gleser Leon J
Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN 37232-6848, USA.
Stat Med. 2005 Aug 30;24(16):2439-56. doi: 10.1002/sim.2118.
In clinical trials it is often desirable to test for non-inferiority and for superiority simultaneously. For such a situation a two-stage adaptive procedure may be advantageous to a conventional single-stage procedure because a two-stage adaptive procedure allows the design of stage II, including the main study objective and sample size, to depend on the outcome of stage I. We propose a framework for designing two-stage adaptive procedures with a possible switch of the primary study objectives at the end of stage I between non-inferiority and superiority. The framework permits control of the type I error rate and specification of the unconditional powers and maximum sample size for each of non-inferiority and superiority objectives. The actions at the end of stage I are predetermined as functions of the stage I observations, thus making specification of the unconditional powers possible. Based on the results at the end of stage I, the primary objective for stage II is chosen, and sample sizes and critical values for stage II are determined.
在临床试验中,常常希望同时检验非劣效性和优效性。对于这种情况,两阶段适应性程序可能比传统的单阶段程序更具优势,因为两阶段适应性程序允许第二阶段的设计(包括主要研究目标和样本量)取决于第一阶段的结果。我们提出了一个设计两阶段适应性程序的框架,在第一阶段结束时主要研究目标可能在非劣效性和优效性之间切换。该框架允许控制一类错误率,并为非劣效性和优效性目标分别指定无条件检验效能和最大样本量。第一阶段结束时的操作根据第一阶段的观察结果预先确定,从而使得指定无条件检验效能成为可能。根据第一阶段结束时的结果,选择第二阶段的主要目标,并确定第二阶段的样本量和临界值。